Annual Cash & Cash Equivalents
$4.25 M
-$6.33 M-59.81%
31 December 2023
Summary:
BioLineRx annual cash & cash equivalents is currently $4.25 million, with the most recent change of -$6.33 million (-59.81%) on 31 December 2023. During the last 3 years, it has fallen by -$12.58 million (-74.72%). BLRX annual cash & cash equivalents is now -76.74% below its all-time high of $18.29 million, reached on 31 December 2012.BLRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$8.84 M
-$787.00 K-8.18%
30 September 2024
Summary:
BioLineRx quarterly cash and cash equivalents is currently $8.84 million, with the most recent change of -$787.00 thousand (-8.18%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+14.35%). BLRX quarterly cash and cash equivalents is now -64.99% below its all-time high of $25.24 million, reached on 01 March 2012.BLRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.8% | +14.3% |
| 3 y3 years | -74.7% | -37.2% |
| 5 y5 years | +25.0% | +80.9% |
BLRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.7% | at low | -37.2% | +107.7% |
| 5 y | 5 years | -74.7% | +25.0% | -49.5% | +107.7% |
| alltime | all time | -76.7% | +72.3% | -65.0% | +301.4% |
BioLineRx Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.84 M(-8.2%) |
| June 2024 | - | $9.62 M(+60.7%) |
| Mar 2024 | - | $5.99 M(+40.8%) |
| Dec 2023 | $4.25 M(-59.8%) | $4.25 M(-44.9%) |
| Sept 2023 | - | $7.73 M(-23.5%) |
| June 2023 | - | $10.10 M(+11.4%) |
| Mar 2023 | - | $9.07 M(-14.4%) |
| Dec 2022 | $10.59 M(-18.5%) | $10.59 M(-19.2%) |
| Sept 2022 | - | $13.11 M(-6.4%) |
| June 2022 | - | $14.00 M(+22.3%) |
| Mar 2022 | - | $11.45 M(-11.9%) |
| Dec 2021 | $12.99 M(-22.8%) | $12.99 M(-7.7%) |
| Sept 2021 | - | $14.08 M(-19.5%) |
| June 2021 | - | $17.48 M(+9.0%) |
| Mar 2021 | - | $16.05 M(-4.7%) |
| Dec 2020 | $16.83 M(+217.7%) | $16.83 M(+156.9%) |
| Sept 2020 | - | $6.55 M(+18.6%) |
| June 2020 | - | $5.52 M(+8.9%) |
| Mar 2020 | - | $5.07 M(-4.2%) |
| Dec 2019 | $5.30 M(+55.6%) | $5.30 M(+8.4%) |
| Sept 2019 | - | $4.88 M(-1.7%) |
| June 2019 | - | $4.97 M(+13.4%) |
| Mar 2019 | - | $4.38 M(+28.8%) |
| Dec 2018 | $3.40 M(-33.4%) | $3.40 M(-27.6%) |
| Sept 2018 | - | $4.70 M(-18.8%) |
| June 2018 | - | $5.79 M(-25.9%) |
| Mar 2018 | - | $7.81 M(+52.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $5.11 M(+107.0%) | $5.11 M(-23.9%) |
| Sept 2017 | - | $6.71 M(-3.4%) |
| June 2017 | - | $6.95 M(+215.6%) |
| Mar 2017 | - | $2.20 M(-10.9%) |
| Dec 2016 | $2.47 M(-55.5%) | $2.47 M(-38.5%) |
| Sept 2016 | - | $4.01 M(+3.5%) |
| June 2016 | - | $3.88 M(-15.4%) |
| Mar 2016 | - | $4.58 M(-17.3%) |
| Dec 2015 | $5.54 M(-4.2%) | $5.54 M(+4.2%) |
| Sept 2015 | - | $5.32 M(-43.4%) |
| June 2015 | - | $9.40 M(+16.5%) |
| Mar 2015 | - | $8.07 M(+39.5%) |
| Dec 2014 | $5.79 M(-34.9%) | $5.79 M(+22.8%) |
| Sept 2014 | - | $4.72 M(-44.1%) |
| June 2014 | - | $8.44 M(-7.5%) |
| Mar 2014 | - | $9.12 M(+2.5%) |
| Dec 2013 | $8.90 M(-51.4%) | $8.90 M(-26.1%) |
| Sept 2013 | - | $12.04 M(-12.6%) |
| June 2013 | - | $13.77 M(+7.9%) |
| Mar 2013 | - | $12.76 M(-30.2%) |
| Dec 2012 | $18.29 M(+110.6%) | $18.29 M(+36.2%) |
| Sept 2012 | - | $13.43 M(-17.7%) |
| June 2012 | - | $16.31 M(-35.4%) |
| Mar 2012 | - | $25.24 M(+190.5%) |
| Dec 2011 | $8.69 M | $8.69 M(-4.0%) |
| Sept 2011 | - | $9.05 M(-18.2%) |
| June 2011 | - | $11.06 M(-29.2%) |
| Mar 2011 | - | $15.63 M |
FAQ
- What is BioLineRx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioLineRx?
- What is BioLineRx annual cash & cash equivalents year-on-year change?
- What is BioLineRx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioLineRx?
- What is BioLineRx quarterly cash and cash equivalents year-on-year change?
What is BioLineRx annual cash & cash equivalents?
The current annual cash & cash equivalents of BLRX is $4.25 M
What is the all time high annual cash & cash equivalents for BioLineRx?
BioLineRx all-time high annual cash & cash equivalents is $18.29 M
What is BioLineRx annual cash & cash equivalents year-on-year change?
Over the past year, BLRX annual cash & cash equivalents has changed by -$6.33 M (-59.81%)
What is BioLineRx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLRX is $8.84 M
What is the all time high quarterly cash and cash equivalents for BioLineRx?
BioLineRx all-time high quarterly cash and cash equivalents is $25.24 M
What is BioLineRx quarterly cash and cash equivalents year-on-year change?
Over the past year, BLRX quarterly cash and cash equivalents has changed by +$1.11 M (+14.35%)